Chen, D.-T.; Saltos, A.N.; Rose, T.; Thompson, Z.J.; Thapa, R.; Chiappori, A.; Gray, J.E.
Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy. Cancers 2023, 15, 2521.
https://doi.org/10.3390/cancers15092521
AMA Style
Chen D-T, Saltos AN, Rose T, Thompson ZJ, Thapa R, Chiappori A, Gray JE.
Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy. Cancers. 2023; 15(9):2521.
https://doi.org/10.3390/cancers15092521
Chicago/Turabian Style
Chen, Dung-Tsa, Andreas N. Saltos, Trevor Rose, Zachary J. Thompson, Ram Thapa, Alberto Chiappori, and Jhanelle E. Gray.
2023. "Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy" Cancers 15, no. 9: 2521.
https://doi.org/10.3390/cancers15092521
APA Style
Chen, D.-T., Saltos, A. N., Rose, T., Thompson, Z. J., Thapa, R., Chiappori, A., & Gray, J. E.
(2023). Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy. Cancers, 15(9), 2521.
https://doi.org/10.3390/cancers15092521
